Enanta Pharmaceuticals Files 8-K
Ticker: ENTA · Form: 8-K · Filed: Aug 5, 2024 · CIK: 1177648
| Field | Detail |
|---|---|
| Company | Enanta Pharmaceuticals Inc (ENTA) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, operations
Related Tickers: ENNT
TL;DR
Enanta Pharma filed an 8-K on Aug 5th for ops/financials - check for details.
AI Summary
Enanta Pharmaceuticals, Inc. filed an 8-K on August 5, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event for the company.
Why It Matters
This filing serves as a public notification of Enanta Pharmaceuticals' operational and financial updates, which is crucial for investors to stay informed about the company's performance.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for reporting operational and financial information, not indicating any immediate adverse events.
Key Players & Entities
- Enanta Pharmaceuticals, Inc. (company) — Registrant
- August 05, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 500 Arsenal Street, Watertown, Massachusetts 02472 (address) — Principal Executive Offices
- (617) 607-0800 (phone_number) — Registrant's Telephone Number
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The provided text of the 8-K filing indicates it is for 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not contain the specific details of these results or updates.
When was this 8-K filing submitted to the SEC?
The filing was submitted on August 5, 2024.
What is Enanta Pharmaceuticals' principal executive office address?
The principal executive offices are located at 500 Arsenal Street, Watertown, Massachusetts 02472.
What is the Commission File Number for Enanta Pharmaceuticals?
The Commission File Number for Enanta Pharmaceuticals is 001-35839.
What is the Standard Industrial Classification (SIC) code for Enanta Pharmaceuticals?
The Standard Industrial Classification code for Enanta Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 441 words · 2 min read · ~1 pages · Grade level 11.4 · Accepted 2024-08-05 16:05:10
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share ENTA Nasdaq Global Select
Filing Documents
- enta-20240805.htm (8-K) — 37KB
- enta-ex99_1.htm (EX-99.1) — 207KB
- img152620751_0.jpg (GRAPHIC) — 16KB
- 0000950170-24-090722.txt ( ) — 390KB
- enta-20240805.xsd (EX-101.SCH) — 24KB
- enta-20240805_htm.xml (XML) — 5KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 5, 2024, Enanta Pharmaceuticals, Inc. announced via press release its results for the fiscal quarter ended June 30, 2024. A copy of Enanta's press release is hereby furnished to the Commission and incorporated by reference herein as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit Number Description 99.1 Press Release of Enanta Pharmaceuticals, Inc. dated August 5, 2024, reporting Enanta's financial results for the fiscal quarter ended June 30, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ENANTA PHARMACEUTICALS, INC. Date: August 5, 2024 By: /s/ Paul J. Mellett Paul J. Mellett Chief Financial and Administrative Officer